Phase II trial of AZD 1446 as an adjunctive treatment to donepezil in patients with mild to moderate Alzheimer's disease.
Phase of Trial: Phase II
Latest Information Update: 30 Jun 2013
At a glance
- Drugs AZD 1446 (Primary) ; Donepezil
- Indications Alzheimer's disease
- Focus Therapeutic Use
- 30 Jun 2013 Status changed from planning to discontinued, according to an AstraZeneca pipeline.
- 09 Jan 2012 New trial record